Clinical trial
Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the…
NCT00421434 · Romark Laboratories L.C., Industry · Completed
Key facts
| NCT number | NCT00421434 |
|---|---|
| Title | Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C |
| Official title | Randomized Study of Nitazoxanide-Peginterferon, Nitazoxanide-Peginterferon-Ribavirin and Peginterferon-Ribavirin in the Treatment of Chronic Hepatitis C |
| Acronym | STEALTHC-1 |
| Lead sponsor | Romark Laboratories L.C., Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Biological, Drug |
| Interventions | Nitazoxanide, Peginterferon alfa-2a, Ribavirin |
| Enrollment | 121 |
| Start date | Jun 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Jan 12, 2007 |
| Last update posted | Sep 25, 2008 |
| Countries | Egypt |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: